Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

APOTEX

  • FDA Approval
  • Feb. 29, 2024, 05:36 UTC
  • 44
  • 0 comments

FDA approve NEBIVOLOL HYDROCHLORIDE

Comment Full text

TORRENT

  • FDA Approval
  • Feb. 29, 2024, 05:36 UTC
  • 48
  • 0 comments

FDA approve ESLICARBAZEPINE ACETATE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Feb. 29, 2024, 05:36 UTC
  • 42
  • 0 comments

FDA approve MYCOPHENOLIC SODIUM

Comment Full text

APOPHARMA A DIV OF APOTEX INC

  • FDA Approval
  • Feb. 28, 2024, 15:23 UTC
  • 48
  • 0 comments

FDA approve LINAGLIPTIN

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Feb. 28, 2024, 15:23 UTC
  • 45
  • 0 comments

FDA approve BRIVARACETAM

Comment Full text

SANDOZ INC

  • FDA Approval
  • Feb. 28, 2024, 15:13 UTC
  • 48
  • 0 comments

FDA approve EDARAVONE

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • Feb. 28, 2024, 15:13 UTC
  • 47
  • 0 comments

FDA approve SUGAMMADEX

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 45
  • 0 comments

FDA approve ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Comment Full text

NOVARTIS

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 44
  • 0 comments

FDA approve DABRAFENIB MESYLATE

Comment Full text

INGENUS PHARMS NJ

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 43
  • 0 comments

FDA approve ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE

Comment Full text
  • Previous
  • 539
  • 540
  • 541
  • 542
  • 543
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328517)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183573)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin